MICROQUIN
MicroQuin is a biotechnology company founded by Dr. Scott Robinson of Imperial College London and Yang Zheng of the University of Chicago. Focused on a novel and broadly impactful target, MicroQuin created smarter therapeutics to address the world’s most challenging diseases, with initial focus on cancer. MicroQuin was a 2018 MassChallenge Finalist (premier global accelerator) and winner of the CASIS/Boeing Prize to fund research on the International Space Station. The company is currently headquartered at the prestigious LabCentral in Kendall Square, Cambridge, MA.
MICROQUIN
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.microquin.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Current Employees Featured
Founder
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - MicroQuin
Newest Events participated
Official Site Inspections
http://www.microquin.com Semrush global rank: 5.28 M Semrush visits lastest month: 1.56 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "MicroQuin"
Space-Based 3D Cell Culture Research Paves the Way for New …
Oct 28, 2024 · Biotechnology startup MicroQuin leveraged the International Space Station (ISS) National Laboratory to grow 3D breast and prostate cancer cell cultures to learn more about …See details»
MicroQuin - Crunchbase Company Profile & Funding
MicroQuin is a biotechnology company founded by Dr. Scott Robinson of Imperial College London and Yang Zheng of the University of Chicago. Focused on a novel and broadly impactful …See details»
MicroQuin to Launch Cancer Research to the ISS - ISS National Lab
KENNEDY SPACE CENTER (FL), February 17, 2022 – An investigation from biotechnology startup MicroQuin launching to the International Space Station (ISS) on Northrop Grumman’s …See details»
Space-Based 3D Cell Culture Research Paves the Way for New …
Oct 28, 2024 · Biotechnology startup MicroQuin leveraged the International Space Station (ISS) National Laboratory to grow 3D breast and prostate cancer cell cultures to learn more about …See details»
Space-based research uncovers key to cancer cell survival
Oct 29, 2024 · Biotechnology startup MicroQuin leveraged the International Space Station (ISS) National Laboratory to grow 3D breast and prostate cancer cell cultures to learn more about …See details»
MicroQuin: hunting down breast cancer - Nature
MicroQuin is engineering first-in-class therapies that hunt out cancerous cells to induce rapid cell death with minimal to no toxicity and immunogenicity.See details»
MicroQuin's Space Research Paves Way for Potential Cancer …
Nov 4, 2024 · Biotechnology startup MicroQuin leveraged the International Space Station (ISS) National Laboratory to grow 3D breast and prostate cancer cell cultures to learn more about …See details»
Venture Principal at Vickers Venture Partners - The Org
Dr. Scott Robinson joined Vickers in 2021 and is based in London, UK and Boston, USA. He is the founder of MicroQuin, a biotechnology company developing novel treatments within …See details»
MicroQuin: hunting down breast cancer - Nature
MicroQuin is engineering first-in-class therapies that hunt out cancerous cells to induce rapid cell death with minimal to no toxicity and immunogenicity. The biotech is breaking the current...See details»
MicroQuin - VentureRadar
Website: https://microquin.com. Creating Next Generation Targeted Treatments for Cancer. Despite advances in new cancer drug modalities, treatment regimens still heavily depend on …See details»
Space-based 3D cell culture research paves th | EurekAlert!
Oct 28, 2024 · Based on this new knowledge, MicroQuin developed a small molecule therapeutic that binds to TMBIM6 and alters how cancer cells regulate intracellular environment changes, …See details»
Space-Based 3D Cell Culture Research Paves The Way For New …
Oct 28, 2024 · Biotechnology startup MicroQuin leveraged the International Space Station (ISS) National Laboratory to grow 3D breast and prostate cancer cell cultures to learn more about …See details»
MicroQuin’s Space-Based Research Uncovers New Pathways in …
Oct 22, 2024 · MicroQuin is a biotech startup that reshapes disease treatment by controlling the intracellular microenvironment. The company recently partnered with the International Space …See details»
Studying Cancer Cell Signaling in Microgravity Conditions Aboard …
Feb 21, 2022 · An investigation from biotechnology startup MicroQuin launching to the International Space Station (ISS) on Northrop Grumman’s 17th Commercial Resupply …See details»
Orbital Oncology: 3D Cell Cultures in Space Reveal the Secret to ...
Oct 17, 2024 · Biotech startup MicroQuin leveraged the International Space Station (ISS) National Laboratory to grow 3D cultures of breast and prostate cancer cells to identify mechanisms …See details»
Yang Zheng - Co-founder at MicroQuin - The Org
In 2018, they Co-founded Oxalo Therapeutics, Inc. and in 2019 they Co-founded MicroQuin. Currently, they are Head of Business Development at Base4. Yang Zheng obtained a Master …See details»
ISS National Laboratory Research by MicroQuin Unveils Pathway …
Nov 1, 2024 · Biotechnology startup MicroQuin leveraged the International Space Station (ISS) National Laboratory to grow 3D breast and prostate cancer cell cultures to learn more about …See details»
MicroQuin Enters Agreement with NIAID to Evaluate MicroQuin ...
Aug 24, 2021 · MicroQuin Ltd will utilize the NIAID's suite of preclinical services to further screen MQPs efficacy across a large array of viruses and assess their efficacy in relevant preclinical …See details»
MicroQuin to launch cancer research to space | EurekAlert!
Feb 18, 2022 · An investigation from biotechnology startup MicroQuin launching to the International Space Station (ISS) on Northrop Grumman’s 17th Commercial Resupply …See details»